Swedish biotech firm will establish HQ next to Moffitt Cancer Center in Tampa

A Sweden-based biotech company that focuses on immunotherapy announced it will establish its U.S. headquarters in Tampa. Vycellix Inc., which was founded by leading medical researchers at Sweden’s world renowned Karolinska Institutet, said its team initially comprising of its senior executive and administrative staff, is scheduled to occupy its new space next to the Moffitt Cancer Center in April, according to the Feb. 21 news release. The headquarters will be located in a 1,500-square-foot…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news